Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CDK9-IN-31 dimaleate

Product Specifications

Target

CDK

Related Pathways

Cell Cycle/Checkpoint

Bioactivity

CDK9-IN-31 dimaleate (Compound Z1) is a compound that acts as an inhibitor of CDK9, effectively suppressing the growth of cancer cells. This compound holds potential for development as an anticancer agent.

Molecular Formula

C32H41ClN6O10S

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Product Datasheet

https://www.targetmol.com/attachment/DataSheet/372420268347359238/T208776

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Recombinant Human STT3A Protein, N-His
bs-105443P-01 20 µg

Recombinant Human STT3A Protein, N-His

Ask
View Details
Recombinant Human STT3A Protein, N-His
bs-105443P-02 50 µg

Recombinant Human STT3A Protein, N-His

Ask
View Details
2,3,4,6-Tetra-O-acetyl-β-D-mannopyranosyl azide
HY-W039936 1 Each

2,3,4,6-Tetra-O-acetyl-β-D-mannopyranosyl azide

Ask
View Details
Natalizumab Biosimilar (Monoclonal, IgG4)
A138714-01 100 µL

Natalizumab Biosimilar (Monoclonal, IgG4)

Ask
View Details
Natalizumab Biosimilar (Monoclonal, IgG4)
A138714-02 100 µL

Natalizumab Biosimilar (Monoclonal, IgG4)

Ask
View Details
mmu-miR-99a-5p miRNA Mimic
MBS8300645-01 5 nmol

mmu-miR-99a-5p miRNA Mimic

Ask
View Details